WO2026059525 - A SOLID ORAL COMPOSITION COMPRISING CARIPRAZINE HYDROCHLORIDE
National phase entry is expected:
Publication Number
WO/2026/059525
Publication Date
19.03.2026
International Application No.
PCT/TR2025/051103
International Filing Date
08.09.2025
Title **
[English]
A SOLID ORAL COMPOSITION COMPRISING CARIPRAZINE HYDROCHLORIDE
[French]
COMPOSITION ORALE SOLIDE COMPRENANT DU CHLORHYDRATE DE CARIPRAZINE
Applicants **
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
SUNEL, Fatih
ATAK, Fadime Bilgehan
IPEK, Celaleddin
PEHLIVAN AKALIN, Nur
GENCAL BOZKURT, Aynur
ARMUT, Merve
OZTAS, Bora
KUCUKGUL, Ayse
Priority Data
2024/011970
10.09.2024
TR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
Turkpatent
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2102 | |
| EPO | Filing, Examination, Granting | 9151 | |
| Japan | Filing, Examination, Granting | 2154 | |
| South Korea | Filing, Examination, Granting | 2132 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,279
Contact Us
Abstract[English]
The present invention relates to a solid oral composition comprising cariprazine hydrochloride and at least one pharmaceutically acceptable excipient, wherein cariprazine hydrochloride has a d (0.9) particle size between 30 µm and 1 µm. The present invention also relates to a simple, rapid, cost effective, time-saving and industrially convenient method of preparing the formulation.[French]
La présente invention concerne une composition orale solide comprenant du chlorhydrate de cariprazine et au moins un excipient pharmaceutiquement acceptable, le chlorhydrate de cariprazine ayant une taille de particule d (0,9) comprise entre 30 µm et 1 µm. La présente invention concerne également un procédé simple, rapide, économique, économe en temps et industriellement pratique pour la préparation de la formulation.